PubRank

Ferry Ossendorp

Author PubWeight™ 56.92‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 CTLs are targeted to kill beta cells in patients with type 1 diabetes through recognition of a glucose-regulated preproinsulin epitope. J Clin Invest 2008 3.11
2 Autoreactive CD8 T cells associated with beta cell destruction in type 1 diabetes. Proc Natl Acad Sci U S A 2005 2.70
3 The inhibiting Fc receptor for IgG, FcγRIIB, is a modifier of autoimmune susceptibility. J Immunol 2011 2.44
4 Proteasome and peptidase function in MHC-class-I-mediated antigen presentation. Curr Opin Immunol 2004 2.27
5 MHC II in dendritic cells is targeted to lysosomes or T cell-induced exosomes via distinct multivesicular body pathways. Traffic 2009 1.98
6 Antigen-antibody immune complexes empower dendritic cells to efficiently prime specific CD8+ CTL responses in vivo. J Immunol 2002 1.66
7 Differential kinetics of antigen-specific CD4+ and CD8+ T cell responses in the regression of retrovirus-induced sarcomas. J Immunol 2002 1.46
8 Antigen processing by nardilysin and thimet oligopeptidase generates cytotoxic T cell epitopes. Nat Immunol 2010 1.24
9 Antigen storage compartments in mature dendritic cells facilitate prolonged cytotoxic T lymphocyte cross-priming capacity. Proc Natl Acad Sci U S A 2009 1.24
10 Distinct uptake mechanisms but similar intracellular processing of two different toll-like receptor ligand-peptide conjugates in dendritic cells. J Biol Chem 2007 1.23
11 Therapeutic cancer vaccines. J Clin Invest 2015 1.23
12 Immune complex-loaded dendritic cells are superior to soluble immune complexes as antitumor vaccine. J Immunol 2006 1.19
13 The minor histocompatibility antigen HA-3 arises from differential proteasome-mediated cleavage of the lymphoid blast crisis (Lbc) oncoprotein. Blood 2003 1.18
14 Controlled local delivery of CTLA-4 blocking antibody induces CD8+ T-cell-dependent tumor eradication and decreases risk of toxic side effects. Clin Cancer Res 2013 1.18
15 Selective cytotoxic T-lymphocyte targeting of tumor immune escape variants. Nat Med 2006 1.17
16 Effective therapeutic anticancer vaccines based on precision guiding of cytolytic T lymphocytes. Immunol Rev 2002 1.16
17 Improved innate and adaptive immunostimulation by genetically modified HIV-1 protein expressing NYVAC vectors. PLoS One 2011 1.16
18 Ins and outs of dendritic cells. Int Arch Allergy Immunol 2006 1.16
19 Vaccine-induced effector-memory CD8+ T cell responses predict therapeutic efficacy against tumors. J Immunol 2012 1.14
20 Prolongation of skin graft survival by modulation of the alloimmune response with alternatively activated dendritic cells. Transplantation 2003 1.03
21 Bi-directional allelic recognition of the human minor histocompatibility antigen HB-1 by cytotoxic T lymphocytes. Eur J Immunol 2002 1.01
22 Discovery of low-affinity preproinsulin epitopes and detection of autoreactive CD8 T-cells using combinatorial MHC multimers. J Autoimmun 2011 1.00
23 Prospects of combinatorial synthetic peptide vaccine-based immunotherapy against cancer. Semin Immunol 2013 0.96
24 TLR ligand-peptide conjugate vaccines: toward clinical application. Adv Immunol 2012 0.95
25 Identification of a novel HLA-B60-restricted T cell epitope of the minor histocompatibility antigen HA-1 locus. J Immunol 2002 0.95
26 Dendritic cells process synthetic long peptides better than whole protein, improving antigen presentation and T-cell activation. Eur J Immunol 2013 0.93
27 Fcγ receptor IIb strongly regulates Fcγ receptor-facilitated T cell activation by dendritic cells. J Immunol 2012 0.91
28 2-Azidoalkoxy-7-hydro-8-oxoadenine derivatives as TLR7 agonists inducing dendritic cell maturation. Bioorg Med Chem Lett 2009 0.89
29 Antitumor efficacy of wild-type p53-specific CD4(+) T-helper cells. Cancer Res 2002 0.88
30 Murine Fc receptors for IgG are redundant in facilitating presentation of immune complex derived antigen to CD8+ T cells in vivo. Mol Immunol 2006 0.88
31 Cationic liposomes loaded with a synthetic long peptide and poly(I:C): a defined adjuvanted vaccine for induction of antigen-specific T cell cytotoxicity. AAPS J 2014 0.85
32 Dendritic cells, but not macrophages or B cells, activate major histocompatibility complex class II-restricted CD4+ T cells upon immune-complex uptake in vivo. Immunology 2006 0.85
33 TAP-independent self-peptides enhance T cell recognition of immune-escaped tumors. J Clin Invest 2016 0.85
34 Gamma irradiation or CD4+-T-cell depletion causes reactivation of latent Salmonella enterica serovar Typhimurium infection in C3H/HeN mice. Infect Immun 2005 0.84
35 Effect of vesicle size on tissue localization and immunogenicity of liposomal DNA vaccines. Vaccine 2011 0.84
36 N-tetradecylcarbamyl lipopeptides as novel agonists for Toll-like receptor 2. J Med Chem 2014 0.84
37 Circulating specific antibodies enhance systemic cross-priming by delivery of complexed antigen to dendritic cells in vivo. Eur J Immunol 2012 0.84
38 Chirality of TLR-2 ligand Pam3CysSK4 in fully synthetic peptide conjugates critically influences the induction of specific CD8+ T-cells. Mol Immunol 2008 0.83
39 Steric hindrance and fast dissociation explain the lack of immunogenicity of the minor histocompatibility HA-1Arg Null allele. J Immunol 2009 0.83
40 CD8 T-cell recognition of human 5T4 oncofetal antigen. Int J Cancer 2006 0.83
41 A novel role of complement factor C1q in augmenting the presentation of antigen captured in immune complexes to CD8+ T lymphocytes. J Immunol 2007 0.83
42 Efficient ex vivo induction of T cells with potent anti-tumor activity by protein antigen encapsulated in nanoparticles. Cancer Immunol Immunother 2013 0.82
43 New role of signal peptide peptidase to liberate C-terminal peptides for MHC class I presentation. J Immunol 2013 0.82
44 Receptor-mediated targeting of cathepsins in professional antigen presenting cells. Angew Chem Int Ed Engl 2009 0.80
45 Effective CD8(+) T cell priming and tumor protection by enterotoxin B subunit-conjugated peptides targeted to dendritic cells. Vaccine 2009 0.80
46 Effective immunotherapy of cancer in MUC1-transgenic mice using clonal cytotoxic T lymphocytes directed against an immunodominant MUC1 epitope. J Immunother 2002 0.79
47 Synthesis of 2-alkoxy-8-hydroxyadenylpeptides: towards synthetic epitope-based vaccines. Bioorg Med Chem Lett 2006 0.79
48 The efficiency of human cytomegalovirus pp65(495-503) CD8+ T cell epitope generation is determined by the balanced activities of cytosolic and endoplasmic reticulum-resident peptidases. J Immunol 2012 0.78
49 New chelation strategy allows for quick and clean 99mTc-labeling of synthetic peptides. Nucl Med Biol 2004 0.77
50 DC-induced CD8(+) T-cell response is inhibited by MHC class II-dependent DX5(+)CD4(+) Treg. Eur J Immunol 2009 0.77
51 Intraendosomal flow cytometry: a novel approach to analyze the protein composition of antigen-loaded endosomes. Eur J Immunol 2012 0.77
52 Synthesis of modified and hybrid protein derived biopolymers. Adv Exp Med Biol 2009 0.75
53 The Optimization of Bioorthogonal Epitope Ligation within MHC-I Complexes. ACS Chem Biol 2016 0.75
54 Evaluation of the high-pressure extrusion technique as a method for sizing plasmid DNA-containing cationic liposomes. J Liposome Res 2011 0.75
55 Particulate Systems Based on Poly(Lactic-co-Glycolic)Acid (pLGA) for Immunotherapy of Cancer. Curr Pharm Des 2015 0.75